Skip to main content

Ikarian Capital, LLC

Position in IMUX — Immunic, Inc.

CIK 1778253 DALLAS, TX

Position in IMUX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$748,874
+$388,605 QoQ
Shares Held
674,662
0.0% QoQ
Ownership
4.95%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Derivatives in IMUX

reported options exposure · as of Mar 31, 2025
CallValue
$693,022
CallShares
635,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $653,059,812 across 106 Biotechnology names. IMUX ranks #73 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMUX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $748,874 674,662
2025-12-31 $360,269 674,662
2025-09-30 $806,297 914,170
2025-06-30 $638,090 914,170
2025-03-31 $996,445 914,170
2025-03-31 $693,022 635,800
2024-12-31 $635,800 635,800
2024-12-31 $1,614,170 1,614,170
2024-09-30 $814,268 493,496
2024-06-30 $547,780 493,496
2024-03-31 $2,128,338 1,612,378
2023-12-31 $675,000 450,000
2023-09-30 $661,500 450,000
2023-06-30 $1,631,500 650,000
2023-03-31 $968,500 650,000
2022-12-31 $910,000 650,000
2022-06-30 $213,405 61,500
2022-06-30 $213,405 61,500
2022-03-31 $694,950 61,500